Pike picked to sit at Quintiles peak

Tom Pike, a 22-year veteran at the management consulting firm Accenture, is taking the helm at biopharma services giant Quintiles. Founder Dennis Gillings is staying on as executive chairman. "Healthcare is the most important industry of the next quarter century, and I'm excited because Quintiles is right at the center of improving the health of millions of people around the world," said Pike. Release

 

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.